Expression of GABARAPL2 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

GABARAPL2 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 271.61

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

370.0

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	981.5
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	942.1
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	802.2
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	785.1
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	703.2
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	674.2
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	648.2
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	647.4
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	628.4
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	624.9
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	609.2
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	567.2
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	565.7
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	544.0
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	539.7
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	532.6
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	527.9
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	525.7
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	524.9
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	520.8
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	519.0
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	489.1
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	486.1
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	476.1
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	467.9
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	449.0
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	448.9
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	444.8
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	444.3
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	444.3
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	443.0
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	438.9
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	438.1
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	435.2
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	435.1
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	426.0
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	422.1
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	418.5
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	418.0
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	414.6
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	405.2
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	405.1
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	403.7
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	399.3
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	398.3
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	397.1
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	395.1
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	395.0
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	392.2
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	383.7
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	382.1
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	380.8
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	373.8
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	372.4
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	372.0
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	370.2
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	370.2
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	368.9
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	367.4
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	367.0
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	366.6
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	365.4
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	362.6
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	362.1
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	359.7
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	358.6
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	353.0
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	352.6
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	352.3
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	348.8
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	347.7
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	345.0
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	342.0
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	341.2
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	340.5
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	339.5
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	338.2
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	336.1
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	335.6
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	334.9
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	332.4
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	329.5
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	327.4
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	322.1
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	321.1
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	320.2
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	315.3
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	312.1
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	310.8
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	310.6
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	306.8
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	303.3
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	303.1
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	298.9
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	297.0
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	296.1
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	294.8
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	293.9
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	292.5
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	291.1
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	290.7
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	288.4
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	287.8
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	286.4
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	286.2
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	283.8
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	279.3
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	278.1
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	275.3
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	273.7
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	269.5
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	267.5
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	260.8
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	258.2
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	252.7
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	252.4
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	247.6
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	245.6
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	242.7
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	242.1
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	240.1
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	240.0
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	237.7
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	235.1
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	233.4
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	229.0
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	226.8
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	218.5
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	210.9
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	210.3
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	196.1
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	195.8
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	186.7
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	185.1
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	185.0
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	178.9
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	168.5
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	162.4
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	138.8
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	118.5
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	101.3
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

GABARAPL2 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 188.3

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

169.5

Number of samples

Samples

Sample	Description	pTPM
AK006	N, NA, stage:NA, dead, 360 days	378.5
AK015	N, NA, stage:NA, alive, 720 days	288.7
AK231	N, NA, stage:NA, dead, 240 days	278.4
AK099	N, NA, stage:NA, dead, 420 days	275.9
AK117	N, NA, stage:NA, dead, 210 days	236.4
AK158	N, NA, stage:NA, dead, 360 days	225.4
AK216	N, NA, stage:NA, dead, 360 days	223.0
AK123	N, NA, stage:NA, dead, 180 days	219.6
AK134	N, NA, stage:NA, dead, 360 days	216.8
AK226	N, NA, stage:NA, dead, 360 days	212.9
AK071	N, NA, stage:NA, dead, 540 days	211.3
AK002	N, NA, stage:NA, dead, 570 days	209.3
AK088	N, NA, stage:NA, dead, 360 days	197.1
AK035	N, NA, stage:NA, dead, 210 days	193.7
AK156	N, NA, stage:NA, dead, 330 days	190.6
AK199	N, NA, stage:NA, alive, 1860 days	186.0
AK124	N, NA, stage:NA, alive, 1920 days	185.4
AK041	N, NA, stage:NA, alive, 810 days	185.1
AK066	N, NA, stage:NA, alive, 960 days	183.9
AK213	N, NA, stage:NA, alive, 2010 days	183.6
AK074	N, NA, stage:NA, alive, 300 days	178.9
AK055	N, NA, stage:NA, dead, 240 days	172.8
AK081	N, NA, stage:NA, dead, 180 days	172.3
AK167	N, NA, stage:NA, dead, 180 days	171.2
AK183	N, NA, stage:NA, alive, 360 days	170.5
AK205	N, NA, stage:NA, dead, 120 days	170.5
AK173	N, NA, stage:NA, dead, 180 days	167.0
AK100	N, NA, stage:NA, alive, 960 days	163.0
AK102	N, NA, stage:NA, alive, 1740 days	162.5
AK139	N, NA, stage:NA, dead, 270 days	161.6
AK005	N, NA, stage:NA, dead, 240 days	161.2
AK195	N, NA, stage:NA, dead, 390 days	157.2
AK142	N, NA, stage:NA, alive, 90 days	156.9
AK091	N, NA, stage:NA, dead, 210 days	156.3
AK089	N, NA, stage:NA, dead, 330 days	155.7
AK085	N, NA, stage:NA, alive, 660 days	155.5
AK003	N, NA, stage:NA, dead, 600 days	153.9
AK030	N, NA, stage:NA, dead, 120 days	153.9
AK098	N, NA, stage:NA, dead, 660 days	152.5
AK079	N, NA, stage:NA, dead, 210 days	143.9
AK049	N, NA, stage:NA, dead, 180 days	141.5
AK133	N, NA, stage:NA, dead, 360 days	139.2
AK178	N, NA, stage:NA, dead, 240 days	139.1
AK149	N, NA, stage:NA, dead, 420 days	137.5
AK076	N, NA, stage:NA, alive, 660 days	134.2
AK218	N, NA, stage:NA, dead, 180 days	134.1
AK051	N, NA, stage:NA, dead, 360 days	133.0
AK165	N, NA, stage:NA, alive, 360 days	131.3
AK227	N, NA, stage:NA, alive, 300 days	122.5
AK188	N, NA, stage:NA, alive, 420 days	115.7
AK103	N, NA, stage:NA, alive, 1320 days	112.2
AK053	N, NA, stage:NA, dead, 300 days	112.2
AK072	N, NA, stage:NA, dead, 150 days	104.0
AK043	N, NA, stage:NA, alive, 660 days	100.8
AK185	N, NA, stage:NA, alive, 330 days	99.9
AK068	N, NA, stage:NA, alive, 360 days	98.5
AK236	N, NA, stage:NA, dead, 360 days	82.2
AK153	N, NA, stage:NA, dead, 240 days	78.0
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0204370003	Normal	1.8
CPT0204400003	Normal	1.6
CPT0204330003	Normal	1.5
CPT0204340003	Normal	1.5
CPT0204410003	Normal	1.5
CPT0204360003	Normal	1.4
CPT0204350003	Normal	1.4
CPT0204380003	Normal	1.4
CPT0204420003	Normal	1.3
CPT0204390003	Normal	1.3
CPT0201710003	Tumor	0.8
CPT0190240004	Tumor	0.5
CPT0168270003	Tumor	0.5
CPT0217880003	Tumor	0.4
CPT0182500003	Tumor	0.3
CPT0206330003	Tumor	0.3
CPT0199770003	Tumor	0.3
CPT0104330003	Tumor	0.3
CPT0218670003	Tumor	0.3
CPT0209440003	Tumor	0.2
CPT0196850003	Tumor	0.2
CPT0093590003	Tumor	0.2
CPT0104220003	Tumor	0.2
CPT0064650003	Tumor	0.2
CPT0162140003	Tumor	0.1
CPT0206110003	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0182550003	Tumor	0.1
CPT0189750004	Tumor	0.1
CPT0206880003	Tumor	0.0
CPT0207030003	Tumor	0.0
CPT0189250003	Tumor	0.0
CPT0125570003	Tumor	0.0
CPT0189650004	Tumor	0.0
CPT0167860004	Tumor	0.0
CPT0168590003	Tumor	0.0
CPT0218890004	Tumor	0.0
CPT0224330003	Tumor	0.0
CPT0189850004	Tumor	0.0
CPT0218830004	Tumor	0.0
CPT0206450003	Tumor	0.0
CPT0125220003	Tumor	-0.1
CPT0219080004	Tumor	-0.1
CPT0002410011	Tumor	-0.1
CPT0224600003	Tumor	-0.1
CPT0217100003	Tumor	-0.1
CPT0189460003	Tumor	-0.1
CPT0125510003	Tumor	-0.1
CPT0205670004	Tumor	-0.1
CPT0216920008	Tumor	-0.2
CPT0182580003	Tumor	-0.2
CPT0218960004	Tumor	-0.2
CPT0167640003	Tumor	-0.2
CPT0167750004	Tumor	-0.2
CPT0064890003	Tumor	-0.3
CPT0171580008	Tumor	-0.3
CPT0186100003	Tumor	-0.3
CPT0217190003	Tumor	-0.3
CPT0087950003	Tumor	-0.3
CPT0207090003	Tumor	-0.3
CPT0206230003	Tumor	-0.3
CPT0071100003	Tumor	-0.3
CPT0225760003	Tumor	-0.3
CPT0162100003	Tumor	-0.3
CPT0217710008	Tumor	-0.4
CPT0221180003	Tumor	-0.4
CPT0162020003	Tumor	-0.4
CPT0228220003	Tumor	-0.4
CPT0189570004	Tumor	-0.4
CPT0175060003	Tumor	-0.4
CPT0168380003	Tumor	-0.4
CPT0167970003	Tumor	-0.4
CPT0218770003	Tumor	-0.4
CPT0205890003	Tumor	-0.4
CPT0127420003	Tumor	-0.4
CPT0093550003	Tumor	-0.4
CPT0217000004	Tumor	-0.4
CPT0087730003	Tumor	-0.5
CPT0206780003	Tumor	-0.5
CPT0087680003	Tumor	-0.5
CPT0208980003	Tumor	-0.5
CPT0224390004	Tumor	-0.5
CPT0224540004	Tumor	-0.6
CPT0093360003	Tumor	-0.6
CPT0217060003	Tumor	-0.6
CPT0092440003	Tumor	-0.6
CPT0205780003	Tumor	-0.6
CPT0225730003	Tumor	-0.7
CPT0218690004	Tumor	-0.7
CPT0078580003	Tumor	-0.7
CPT0206000004	Tumor	-0.7
CPT0190360004	Tumor	-0.7
CPT0089150003	Tumor	-0.7
CPT0205570003	Tumor	-0.7
CPT0205450004	Tumor	-0.7
CPT0168480003	Tumor	-0.7
CPT0127480003	Tumor	-0.7
CPT0093510003	Tumor	-0.8
CPT0167530003	Tumor	-0.8
CPT0079790003	Tumor	-0.8
CPT0206560003	Tumor	-0.8
CPT0123530003	Tumor	-0.8
CPT0168830003	Tumor	-0.8
CPT0217430008	Tumor	-0.9
CPT0161730003	Tumor	-0.9
CPT0218330004	Tumor	-0.9
CPT0206670004	Tumor	-0.9
CPT0087570003	Tumor	-1.0
CPT0093450003	Tumor	-1.1
CPT0168080003	Tumor	-1.4
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA036726
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade
Glioma, malignant, High grade Glioblastoma, NOS